William J. Sandborn - 15 May 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
President and Chief Medical Officer
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Issuer symbol
VTYX
Transactions as of
15 May 2023
Net transactions value
-$126,528
Form type
4
Filing time
16 May 2023, 19:10:21 UTC
Previous filing
01 May 2023
Next filing
01 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Options Exercise $654 +3,272 +9.4% $0.2000* 38,149 15 May 2023 By Spouse
transaction VTYX Common Stock Sale $71,378 -1,978 -5.2% $36.09 36,171 15 May 2023 By Spouse F1, F2
transaction VTYX Common Stock Sale $48,273 -1,309 -3.6% $36.88 34,862 15 May 2023 By Spouse F1, F3
transaction VTYX Common Stock Sale $7,532 -200 -0.57% $37.66 34,662 15 May 2023 By Spouse F1, F4
holding VTYX Common Stock 48,389 15 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (Right to Buy) Options Exercise $0 -3,272 -14% $0.000000 20,922 15 May 2023 Common Stock 3,272 $0.2000 By Spouse F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
F2 Represents the weighted average share price of an aggregate total of 1,978 shares sold in the price range of $35.4917 to $36.4819. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average share price of an aggregate total of 1,309 shares sold in the price range of $36.545 to $37.43. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $37.635 to $37.68. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 Subject to the Reporting Person's spouse continuing to be a Service Provider (as defined in the Issuer's 2019 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019.

Remarks:

President and Chief Medical Officer